MS Drug on Glioblastoma Graphic; UcC San Diego School of Medicine (IMAGE)
Caption
In a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the targeted cancer drug BKM-120.
Credit
UC San Diego School of Medicine
Usage Restrictions
Use caption and credited as indicated.
License
Licensed content